PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555481
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555481
Gene Amplification Technology Market size was valued at USD 27,154.6 Million in 2023, expanding at a CAGR of 3.00% from 2024 to 2032.
Genomic technology, which is commonly utilized in diagnostics, includes gene amplification technology. In numerous studies, it aids in increasing the copy number of a gene. Dendritic polymers, transcription-mediated amplification, ligase chain reaction, and polymerase chain reaction are frequently used methods for amplifying genes. The main application of gene amplification technology is the comparison of the sample's genes with those of other germline or somatic cells.
Gene Amplification Technology Market- Market Dynamics
Increased Need for Genetic Data Collection to Identify and Map Every Gene in the Human Genome is Driving the Global Market to Expand
The differential expansion of a particular genomic area in comparison to the remainder is known as gene amplification. This process has been shown to occur in both somatic and germline cells, and it appears to be carried out by most animals. Gene amplification can affect an organism negatively or positively, promoting growth or survival, for example. It may be connected to typical developmental processes or arise as a result of random genetic occurrences. There has been a lot of recent research on somatic cell gene amplification in human cancers. Tumor development may result from or be facilitated by proto-oncogene amplification. Sometimes the amplified gene can be a good target for cancer therapy. The growth of a specific DNA from a very small volume is mentioned. The global market is growing as a result of an increase in demand for genetic data collection to map and identify every gene in the human genome. The increasing adoption of particular cancer treatments is driving the global market for gene amplification technology. The main driver of the gene amplification technology market is still human genome projects (HGP).
Gene Amplification Technology Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.00% over the forecast period (2024-2032)
Based on technology segmentation, the PCR-based amplification category was the leading segment in 2023
Based on downstream application segmentation, the hybridization category was the leading segment in 2023
Based on sample type segmentation, the FFPE category was predicted to show maximum market share in the year 2023
Based on product segmentation, the instruments category was the leading segment in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Gene Amplification Technology Market is segmented based on Technology, Downstream Application, Sample Type, Product, End-use, and Region.
The market is divided into the following categories based on technology: PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification, and Others. The PCR-based amplification category dominates the market. This is explained by the fact that PCR technology is widely applied in a variety of end-use applications. Furthermore, the widespread use of PCR for COVID-19 detection has generated a sizable amount of income for this technology.
The market is divided into three categories based on sample type: Single Cell, FFPE, and Others. The commercial category dominates the market and is likely to maintain its dominance during the forecast period. Samples known as formalin-fixed paraffin embedded (FFPE) offer a vast reservoir of biomaterials for use in biomedical research, particularly in the field of cancer etiology. Nearly 90% of tissue samples utilized in clinical settings have been treated with formalin. Studying gene expression in these clinically significant samples is attracting a lot of interest from researchers.
Gene Amplification Technology Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Throughout the forecast period, North America is anticipated to hold the greatest share of the global market for Gene Amplification Technology. The main drivers of the North American market's expansion include robust research, a growing market for gene-multiplication products, and the region's numerous genetic research initiatives. Additionally, a sizable portion of businesses involved in the production and marketing of gene amplification solutions-that is, kits, reagents, and instruments-have their main offices in the United States. This element also played a role in the region's high revenue generation. For instance, New England BioLabs, Inc. (Massachusetts, U.S.) released the Luna SARS-CoV-2 RT-qPCR Assay Kit in January 2021 to identify SARS-CoV-2 nucleic acid.
In addition, the Gene Amplification Technology market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific because of encouraging government programs to build out the infrastructure for healthcare. The market expansion in rising nations, like China and India, has been boosted by factors like the easy availability of skilled labor and increased research efforts in the field of genomics and molecular diagnostics. For instance, Chinese researchers created a rolling circle amplification-based ultrasensitive and quick ELISA test in April 2021 for the early diagnosis of a variety of disorders.
In the upcoming years, the Gene Amplification Technology industry is anticipated to rise at an impressive rate. Several prominent players in the global gene amplification technology market include QIAGEN, New England Biolabs, Illumina Inc., Yikang Gene, Bio-Rad Laboratories, and Silicon Biosystems, among others. The market competition has gotten more intense due to operating participants' expanding product portfolios and the rise in technological partnerships between operating entities. To increase their market presence, the operational entities are also pursuing several strategic activities, including licensing, partnerships, and mergers and acquisitions. The market has seen some significant mergers and acquisitions in recent years.
December 2023: According to NGeneBio, the business has filed a domestic patent for its next-generation sequencing (NGS)--based tuberculosis (TB) diagnosis technique. This patent is for a "Composition for gene amplification for detecting drug resistance in mycobacterium tuberculosis and its use." For $85 million, Moderna, Inc. purchased OriCiro Genomics K.K. in January 2023. OriCiro Genomics K.K. will offer knowledge of cell-free DNA synthesis and amplification technologies.
November 2022: An alliance was revealed between China-based biotech startup Biotheus and eminent scientific and technology giant Merck, which specializes in creating therapies for autoimmune disorders and cancer. Biotheus' turn-around time (TAT) for characterizing its cell lines dropped from about 60 days to 14 days by using Merck's Blazar Rodent Panel.